As of August 28, 2026, Takeda Pharmaceutical Company Limited (TAK) has a DilutionWatch DilutionScore of 12/100, rated LOW dilution risk. Takeda Pharmaceutical Company Limited has a market capitalization of $50.43B, 1.56B shares outstanding, 179 institutional holders tracked.
This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.
Dilution Forecast
☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for TAK.
Market Data
Market Cap$50.43B
Shares Outstanding1.56B
Float1.58B
Cash$3.74B
Debt$34.24B
Short InterestN/A
Institutional Holdings
QoQ: ↑ 19.0% shares (2026Q1 vs prior)
179 institutional holders · 75.42M shares
#1
Frazier Life Sciences Management, L.P.
12.47M shares
#2
Medicxi Ventures Management (Jersey) Ltd
7.46M shares
#3
VANGUARD CAPITAL MANAGEMENT LLC
5.17M shares
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Short Interest2.87M
Days to Cover1.0
% of Float0.2%
FINRA data as of Jul 31, 2026
Recent SEC Activity
No recent SEC insights
Recent News
No recent news
Track TAK Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking TAK — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
More Research for TAK
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.